ASX-Dividend-Report-Banner

Lifespin GmbH and Acıbadem Forge a Groundbreaking Metabolomics Partnership to Advance Personalized Medicine

May 28, 2024 04:00 PM AEST | By Cision
 Lifespin GmbH and Acıbadem Forge a Groundbreaking Metabolomics Partnership to Advance Personalized Medicine
Image source: Kalkine Media

ISTANBUL and REGENSBURG, Germany, May 28, 2024 /PRNewswire/ -- lifespin GmbH, a pioneer in health status detection software, has teamed up with Acıbadem University (ACU) and Acıbadem Healthcare Group (AHG) to launch a comprehensive precision medicine initiative, a significant stride towards revolutionizing personalized healthcare. This collaboration is set to develop and expand the global market for innovative healthcare solutions that utilize a combination of advanced Nuclear Magnetic Resonance (NMR) and AI technologies.

Under the agreement, lifespin GmbH and ACU will combine their expertise to establish a state-of-the-art, AI-enabled, NMR-based metabolomics precision medicine platform. This joint venture will focus on deploying lifespin's cutting-edge products across ACU's extensive network through a Software as a Service (SaaS) model, offering these technologies at competitive rates.

Transformative Healthcare Across Continents

The partnership's mission extends beyond improving patient care across Eurasia; it ambitiously targets expansion into Africa and the Arabian Peninsula, with Istanbul positioned as the central hub. Moreover, this strategic alignment promises to bridge continents with top-tier healthcare solutions, enhancing access to advanced healthcare diagnostics.

"We are thrilled to collaborate with Acıbadem University to push the boundaries of AI-based precision medicine tools in the healthcare provider sector," said Dr. Ali Tinazli, CEO of lifespin GmbH. "Our combined efforts will not only advance medical technology but also make these tools for personalized medicine more accessible."

Prof. Dr. Ahmet Şahin, representative of Acıbadem University, commented: "This partnership stands as a testament to our commitment to healthcare innovation. We aim to transform the landscape of medicine, making personalized healthcare a reality for millions."

In addition to commercial endeavors, lifespin and Acıbadem University are eager to explore opportunities for joint development of new healthcare solutions as well as the digitalization of ACU's extensive biobank.

The agreement also encompasses the creation of a Regional Data Analysis and Data Production Center Laboratory, which will support the development and distribution of lifespin's products globally.  

For further information, please contact:

Dr. Ali Tinazli, lifespin GmbH
[email protected]
+49-160-2573458

Prof. Dr. Ahmet Şahin, Acıbadem University
[email protected]

For more information, visit:

Lifespin GmbH, www.lifespin.health
Acıbadem, https://www.acibadem.com.tr/en/ 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.